Combining mathematical modeling and deep learning to make rapid and explainable predictions of the patient-specific response to anticoagulant therapy under venous flow.


Journal

Mathematical biosciences
ISSN: 1879-3134
Titre abrégé: Math Biosci
Pays: United States
ID NLM: 0103146

Informations de publication

Date de publication:
07 2022
Historique:
received: 25 09 2021
revised: 19 04 2022
accepted: 21 04 2022
pubmed: 4 5 2022
medline: 16 6 2022
entrez: 3 5 2022
Statut: ppublish

Résumé

Anticoagulant drugs are commonly prescribed to prevent hypercoagulable states in patients with venous thromboembolism. The choice of the most efficient anticoagulant and the appropriate dosage regimen remain a complex problem because of the intersubject variability in the coagulation kinetics and the effect of blood flow. The rapid assessment of the patient-specific response to anticoagulant regimens would assist clinical decision-making and ensure efficient management of coagulopathy. In this work, we introduce a novel approach that combines computational modeling and deep learning for the fast prediction of the patient-specific response to anticoagulant regimens. We extend a previously developed model to explore the spatio-temporal dynamics of thrombin generation and thrombus formation under anticoagulation therapy. Using a 1D version of the model, we generate a dataset of thrombus formation for thousands of virtual patients by varying key parameters in their physiological range. We use this dataset to train an artificial neural network (ANN) and we use it to predict patient's response to anticoagulant therapy under flow. The algorithm is available and can be accessed through the link: https://github.com/MPS7/ML_coag. It yields an accuracy of 96 % which suggests that its usefulness can be assessed in a randomized clinical trial. The exploration of the model dynamics explains the decisions taken by the algorithm.

Identifiants

pubmed: 35504312
pii: S0025-5564(22)00038-4
doi: 10.1016/j.mbs.2022.108830
pii:
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108830

Informations de copyright

Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Anass Bouchnita (A)

Department of Integrative Biology, University of Texas at Austin, 78712 Austin, TX, USA. Electronic address: anass.bouchnita@austin.utexas.edu.

Patrice Nony (P)

UMR 5558 CNRS, Université Claude Bernard Lyon 1, 69100 Lyon, France.

Jean-Pierre Llored (JP)

Ecole Centrale Casablanca, Casablanca 20000, Morocco.

Vitaly Volpert (V)

Institut Camille Jordan, UMR 5208 CNRS, University Claude Bernard Lyon 1, 69622 Villeurbanne, France; People's Friendship University of Russia (RUDN), 117198 Moscow, Russian Federation.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH